To investigate if CSF-1 signaling specifically from tumor cells drives TMEM doorway opening in vivo, we utilized a patient-derived xenograft model previously described [15, 27, 28], orthotopically transplanting human HT17 tumors into SCID mice. The gene discussed is CSF1; the disease is neoplasm.